Skip Navigation

News: Overview
The latest news from Mercury Therapeutics, Inc.

The American Diabetes Association has estimated that the economic cost of diabetes to the U.S. economy in 2007 exceeded 174 billion dollars.

August 4th, 2009 
Debiopharm Group and Mercury Therapeutics, Inc. sign an exclusive license agreement for the development and commercialisation of Debio 0930

HTML

PDF
June 16th, 2008 
AMPK activator compounds demonstrate significant oral bioavailability

HTML

PDF
March 31st, 2008 
Patents filed on lead compounds that directly and specifically activate AMPK

HTML

PDF
March 17th, 2008 
Marquant Partners LLC appointed to advise on strategic and partnering opportunities

HTML

PDF
March 12th, 2008 
Lead series of indirect AMPK activators licensed to Makoto Life Sciences

HTML

PDF
November 26th, 2007
Significant progress made in small molecule AMPK activator development Program. Promising preclinical results anticipated before the end of Q4

HTML

PDF
Link to Download Adobe Acrobat Reader

News Articles are available to view and download in PDF format. You will need Adobe Acrobat Reader to view them.